[1]
“THE RELATIONSHIP BETWEEN COVID-19 SEVERITY AND THE USAGE OF ANGIOTENSIN-II RECEPTOR BLOCKERS IN HYPERTENSIVE PATIENTS”, Bioresearch Communications, vol. 9, no. 1, pp. 1180–1195, Dec. 2022, doi: 10.3329/brc.v9i1.63598.